Financials
- Market Capitalization 292.75 M
- Employee 92
- Founded 2019
- CEO N/A
- Website www.neumoratx.com
- Headquarter Delaware, United States
- FIGI BBG012W9C4X1
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3323 | LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.23 USD | +0.82% | -6.82% | -0.81% | -28.36% | 306.64 M USD | ||
| 3347 | INDP Indaptus Therapeutics, Inc. - Common Stock | 2.63 USD | 0.00% | +1.54% | -30.61% | +38.42% | 297.83 M USD | ||
| 3374 | IRD Opus Genetics, Inc. - Common Stock | 3.56 USD | -6.56% | -11.44% | -8.95% | -4.30% | 289.77 M USD | ||
| 3381 | TTRX Turn Therapeutics Inc. - Common Stock | 9.64 USD | +1.80% | +2.77% | +47.85% | -3.60% | 287.16 M USD |
Frequently asked questions about Neumora Therapeutics, Inc. - Common Stock
What is the Neumora Therapeutics, Inc. - Common Stock stock price today?
The current price of Neumora Therapeutics, Inc. - Common Stock (NMRA) is 1.58. Over the past 24 hours, the stock has changed by -1.25%. Follow the NMRA chart for real-time price dynamics.
What is the stock ticker of Neumora Therapeutics, Inc. - Common Stock?
Neumora Therapeutics, Inc. - Common Stock trades under the ticker NMRA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Neumora Therapeutics, Inc. - Common Stock stock going up?
NMRA has changed by -7.60% over the last week, +66.32% over the last month, and +3.27% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Neumora Therapeutics, Inc. - Common Stock net income for the last quarter?
Neumora Therapeutics, Inc. - Common Stock reported net income of -53.46 M for the last quarter. The previous quarter showed -59.45 M, which means net income changed by +10.08%.
How many employees does Neumora Therapeutics, Inc. - Common Stock have?
As of the latest available data, Neumora Therapeutics, Inc. - Common Stock has 92 employees. Workforce size can provide additional context about the company's scale and operations.
What is Neumora Therapeutics, Inc. - Common Stock EBITDA?
Neumora Therapeutics, Inc. - Common Stock EBITDA is -52.78 M, and its EBITDA margin is -74.35 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Neumora Therapeutics, Inc. - Common Stock stock?
You can buy Neumora Therapeutics, Inc. - Common Stock (NMRA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Neumora Therapeutics, Inc. - Common Stock stock?
Investing in Neumora Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NMRA chart and related analysis on metatrader.com as part of your research.